[The absolute lymphocyte count in Hodgkin's disease as an aid in survival prognosis]

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

Oncology reports·2011

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

Oncology reports·2011

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

International journal of oncology·2011

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

International journal of oncology·2011

Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.

European journal of cancer (Oxford, England : 1990)·2002

Autoimmune and inflammatory diseases associated with T-cell clonal expansion.

Haematologica·2026

Macrophage-specific LAMTOR2 deletion disrupts systemic iron homeostasis in mice.

Haematologica·2026

Dual inhibition of JAK and MEK suppresses T-cell acute lymphoblastic leukemia induced by mutant IL7R and RASGRP1 overexpression.

Haematologica·2026

Validation of the International Working Group 2023 response criteria for higher risk myelodysplastic syndromes/neoplasms using the International Consortium for Myelodysplastic Syndromes VALIDATE database and a randomized phase III trial.

Haematologica·2026

Preserving anthracycline-containing treatment in older patients with classical Hodgkin lymphoma: a role for liposomal doxorubicin. Comment on: "Age, anthracycline and mortality in 28,000 classic Hodgkin lymphoma patients: cohort study of a complete population".

Haematologica·2026

Mesenchymal stem cells in ribosomal insufficiency lead to aberrant osteoblastic differentiation and altered hematopoiesis.

Haematologica·2026

Persistent Immune Thrombocytopenia as a Post-Acute Sequelae of COVID-19: A Case Report.

Public health challenges·2026

Endocrine dysfunctions in patients with beta thalassemia major: a single-center retrospective study from Basrah.

F1000Research·2026

Neutrophil-derived S100A8/A9 is associated with inflammation that supports Dnmt3a-mutant hematopoiesis.

Haematologica·2026

Monocyte Galectin-9 is associated with CD8⁺ T-cell dysfunction and early relapse after haploidentical hematopoietic stem cell transplantation.

Biomarker research·2026

Hyperacute Graft-Versus-Host Disease.

Bone marrow transplantation·2026

PNH clone distribution in aplastic anaemia: heterozygous germline carriers exhibit immune-mediated clone patterns rather than inherited bone marrow failure phenotype.

Pathology·2026

Related Experiment Videos

[The absolute lymphocyte count in Hodgkin's disease as an aid in survival prognosis]

Related Concept Videos

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry.

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.

Autoimmune and inflammatory diseases associated with T-cell clonal expansion.

Macrophage-specific LAMTOR2 deletion disrupts systemic iron homeostasis in mice.

Dual inhibition of JAK and MEK suppresses T-cell acute lymphoblastic leukemia induced by mutant IL7R and RASGRP1 overexpression.

Validation of the International Working Group 2023 response criteria for higher risk myelodysplastic syndromes/neoplasms using the International Consortium for Myelodysplastic Syndromes VALIDATE database and a randomized phase III trial.

Preserving anthracycline-containing treatment in older patients with classical Hodgkin lymphoma: a role for liposomal doxorubicin. Comment on: "Age, anthracycline and mortality in 28,000 classic Hodgkin lymphoma patients: cohort study of a complete population".

Mesenchymal stem cells in ribosomal insufficiency lead to aberrant osteoblastic differentiation and altered hematopoiesis.

Persistent Immune Thrombocytopenia as a Post-Acute Sequelae of COVID-19: A Case Report.

Endocrine dysfunctions in patients with beta thalassemia major: a single-center retrospective study from Basrah.

Neutrophil-derived S100A8/A9 is associated with inflammation that supports Dnmt3a-mutant hematopoiesis.

Monocyte Galectin-9 is associated with CD8⁺ T-cell dysfunction and early relapse after haploidentical hematopoietic stem cell transplantation.

Hyperacute Graft-Versus-Host Disease.

PNH clone distribution in aplastic anaemia: heterozygous germline carriers exhibit immune-mediated clone patterns rather than inherited bone marrow failure phenotype.

Related Experiment Videos

[The absolute lymphocyte count in Hodgkin's disease as an aid in survival prognosis]

Related Concept Videos

Related Articles